Treating patients for opioid use disorder in the hospital leads to better outcomes after they are discharged, study finds
Peer-Reviewed Publication
Updates every hour. Last Updated: 14-May-2025 17:09 ET (14-May-2025 21:09 GMT/UTC)
Experimental drug NU-9 — a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials for the treatment of amyotrophic lateral sclerosis (ALS) — improves neuron health in animal models of Alzheimer’s disease, according to a new Northwestern University study.
In the first comprehensive, cell-by-cell analysis of brain tissue from individuals with Tourette syndrome, researchers have pinpointed exactly which cells are perturbed and how they malfunction, revealing how different types of brain cells are affected by the condition. Findings from this groundbreaking study in Biological Psychiatry, published by Elsevier, provide unprecedented insights into the interplay of different brain cell types in Tourette syndrome, suggesting new therapeutic directions.